Skip to record
ExecutivesRichard Heyman, Ph.D.

Executive record

Richard Heyman, Ph.D.

Director at PMV Pharmaceuticals, Inc.

Follow record
More
Challenge a Claim

Alpha ID: alpha:person:richard-heyman-ph-dVersion: public-0As of: 2026-10-03

Not yet claimed7 published Claims3 sources
  • Director

Leadership, in context.

Connect capital, control, accountability, and evidence.

Published Claims7Within this recordEvidence sources3Inspect provenance and dates

Explore the record

ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.

Key Claims

Biography

Dr. Heyman has served as Chairperson and director since June 2020 and will not stand for re-election at the 2026 Annual Meeting. He is a scientist with 25 years of biotech experience and co-founder of multiple companies including Aragon Pharmaceuticals (acquired by J&J) and Seragon Pharmaceuticals (acquired by Roche). He is currently Chairman of ORIC Pharmaceuticals and Architect Therapeutics.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.